Search Results - "Alencar, Allan K.N"
-
1
N -acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity
Published in International journal of cardiology (01-05-2014)“…Abstract Background Pulmonary arterial hypertension (PAH) is a disease that results in right ventricular (RV) dysfunction. While pulmonary vascular disease is…”
Get full text
Journal Article -
2
Novel Agonist of Adenosine Receptor Induces Relaxation of Corpus Cavernosum in Guinea Pigs: An In Vitro and In Vivo Study
Published in Urology (Ridgewood, N.J.) (01-05-2015)“…Objective To test the relaxation effect of a new adenosine receptor agonist N -acylhydrazone derivative, 3,4-dimethoxyphenyl- N -methyl-benzoylhydrazide…”
Get full text
Journal Article -
3
Sacubitril/Valsartan: A Breakthrough in Heart Failure Management - Addressing Quality of Life and Mortality
Published in Arquivos brasileiros de cardiologia (01-01-2023)Get full text
Journal Article -
4
Cardioprotection Induced by Activation of GPER in Ovariectomized Rats With Pulmonary Hypertension
Published in The journals of gerontology. Series A, Biological sciences and medical sciences (10-08-2018)“…Abstract Pulmonary hypertension (PH) is a disease of women (female-to-male ratio 4:1), and is associated with cardiac and skeletal muscle dysfunction. Herein,…”
Get full text
Journal Article -
5
Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension
Published in Frontiers in pharmacology (04-12-2017)“…Pulmonary arterial hypertension (PAH) is a clinical condition characterized by pulmonary arterial remodeling and vasoconstriction, which promote chronic vessel…”
Get full text
Journal Article -
6
Can Epigenetics Help Solve the Puzzle Between Concomitant Cardiovascular Injury and Severity of Coronavirus Disease 2019?
Published in Journal of cardiovascular pharmacology (01-04-2022)“…The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has significant implications in patients with concomitant cardiovascular disease…”
Get full text
Journal Article -
7
Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline‐induced pulmonary hypertension in rats
Published in British journal of pharmacology (01-07-2013)“…Background and Purpose Pulmonary arterial hypertension (PAH) is characterized by enhanced pulmonary vascular resistance, right ventricular hypertrophy and…”
Get full text
Journal Article -
8
Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice
Published in Frontiers in pharmacology (06-12-2018)“…Pulmonary arterial hypertension (PAH) is a disease characterized by an increase in pulmonary vascular resistance and right ventricular (RV) failure. We aimed…”
Get full text
Journal Article -
9
Reduction of cardiac and renal dysfunction by new inhibitor of DPP4 in diabetic rats
Published in Pharmacological reports (01-12-2019)“…Increased mortality due to type 2 diabetes mellitus (T2DM) has been associated with renal and/or cardiovascular dysfunction. Dipeptidyl dipeptidase-4…”
Get more information
Journal Article